HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Collaboration Between U.S., EU Chemicals Agencies To Include Data-Sharing

This article was originally published in The Rose Sheet

Executive Summary

An agreement between the U.S. Environmental Protection Agency and the European Chemicals Agency will promote the exchange of chemicals safety information between parties, likely giving EPA access to data collected under the REACH program.

You may also be interested in...



First REACH Deadline Accumulates Data On "Most Problematic" Chemicals

The European Chemicals Agency has greater insight into the safety of the "most problematic" substances following the Nov. 30 deadline under the EU's Registration, Evaluation, Authorization and Restriction of Chemicals law.

Environmental Safety Regs For Cosmetic Chemicals On Council’s Radar In ‘09

The Personal Care Products Council is keeping an eye out for state and federal legislation aimed at providing "the next level" of chemicals safety by chronicling an ingredient's environmental effects

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel